[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Chris T. Hyder, EVP—Group President, Health & Hygiene at The Clorox Company (CLX), reported an equity award conversion on 09/16/2025. The filing shows the acquisition of 7,208 shares of Clorox common stock at an indicated price of $124.85 per share, bringing his total beneficial ownership to 29,325 shares. The shares arise from Restricted Stock Units that vest in four equal installments, with one-quarter vesting on each of October 5, 2026, 2027, 2028 and 2029. The Form 4 was signed by an attorney-in-fact on 09/18/2025. This disclosure records an insider share increase tied to compensation rather than an open-market purchase.

Insights

Securities Analyst

TL;DR: Insider received 7,208 shares via RSU conversion, increasing holdings to 29,325 shares; vesting is staggered through 2029.

The transaction is a standard compensation-related conversion of Restricted Stock Units into common shares at an indicated price of $124.85 per share on 09/16/2025. The incremental ownership is modest relative to typical institutional positions and should be viewed as routine executive compensation vesting rather than a signal of a material change in insider conviction. The four-year vesting schedule (annual 1/4 installments from Oct 5, 2026 to Oct 5, 2029) aligns management incentives with multi-year performance and retention goals.

Corporate Governance Expert

TL;DR: This Form 4 documents routine RSU settlement with multi-year vesting, reflecting standard retention-based equity alignment.

The disclosure indicates governance-aligned compensation practice: RSUs converted to 7,208 shares with clear vesting dates and no derivative instruments disclosed. Filing by an attorney-in-fact and reporting of total beneficial ownership (29,325 shares) meet Section 16 reporting requirements. There are no signs in the filing of accelerated vesting, related-party transfers, or atypical exemptions that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hyder Chris T

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP-Group Pres -Hlth & Hyg

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		A(1)		7,208	A	$124.85	29,325	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028 and 2029.

	By Jinho Joo, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Chris T. Hyder report on the Form 4 for CLX?

The Form 4 reports the acquisition of 7,208 shares of Clorox common stock on 09/16/2025, at an indicated price of $124.85 per share.

How many Clorox shares does the reporting person beneficially own after the transaction?

Following the reported transaction the filing shows the reporting person beneficially owns 29,325 shares.

Are the acquired shares from grants or open-market purchases?

The shares arise from Restricted Stock Units (RSUs) that converted to common stock; this is a compensation-related acquisition, not an open-market purchase.

What is the RSU vesting schedule disclosed in the filing?

The RSUs vest in four equal installments: 1/4 on each of Oct 5, 2026, 2027, 2028, and 2029.

When was the Form 4 signed and by whom?

The Form 4 was signed by an attorney-in-fact, Jinho Joo, on 09/18/2025.